XML 65 R13.htm IDEA: XBRL DOCUMENT
v3.19.3

NOTE RECEIVABLE | 9 Months Ended
--- | ---
Sep. 30, 2019
Notes to Financial Statements |
NOTE RECEIVABLE |
6. | NOTE RECEIVABLE
Note receivable consists of the following at:
|  | September 30, |  |  | December 31, |
|  | 2019 |  |  | 2018 |
Note Receivable-current |  | $ | 1,149,791 |  |  | $ | - |
Note Receivable-non-current |  |  | 10,348,115 |  |  |  | - |
Total Note Receivable |  | $ | 11,497,906 |  |  | $ | - |
On January 1, 2019, the Company entered into a license and repayment of investment agreement with Qifeng Food Technology (Beijing) Co., Ltd (“Qifeng”). Under the agreement, Qifeng will repay the market investment Celsius has made into China to date, over a five-year period, under an unsecured, interest-bearing note receivable (“Note”). The initial outstanding principal under the Note was approximately $12.2 million which is denominated in Chinese Renminbi (CNY) and was recorded as Other Income on the Consolidated Statements of Operations. The amount recognized considered the net of the balances of the accounts receivable, accounts payable and accrued expenses, as well as the marketing investments that were performed in the China market. Scheduled principal payments plus accrued interest are due annually on March 31 of each year starting in 2020. The Note is recorded at amortized cost basis and accrues interest at a rate per annum equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million. For the nine months ended September 30, 2019, the weighted average interest rate was 3.21% and interest income was $288,070. The Company assesses the Note for impairment periodically by evaluating whether it is probable that the Company will be unable to collect all the contractual interest and principal payments as scheduled in the Note agreement, based on historical experience about Qifeng’s ability to pay, the current economic environment and other factors. If the Note is determined to be impaired, the impairment is measured based on the present value of the expected future cash flows under the Note, discounted at the Note’s effective interest rate. At September 30, 2019, the Note was not deemed to be impaired.

X
- Definition The entire disclosure for information about notes receivable. + References No definition available. + Details
Name: | celh_NoteReceivableTextBlock
Namespace Prefix: | celh_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | celh_NotesToFinancialStatementsAbstract
Namespace Prefix: | celh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration